Heiko Konig

6PUBLICATIONS
13CO-AUTHORS
Haematological tumoursMolecular targetsGene and molecular therapyMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 18, 2021
Pharmacological inhibition of Carbonic Anhydrase IX and XII to enhance targeting of acute myeloid leukaemia cells under hypoxic conditions.

Fangli Chen, Emilia Licarete, Xue Wu

|Jul 02, 2021
Engineering Tools for Regulating Hypoxia in Tumour Models.

Min Hee Kim, Steven D Green, Chien-Chi Lin

|May 27, 2021
CD123-targeted therapy in acute myeloid leukemia.

Manuel Ricardo Espinoza-Gutarra, Steven D Green, Joshua F Zeidner

|May 26, 2020
Classic and targeted anti-leukaemic agents interfere with the cholesterol biogenesis metagene in acute myeloid leukaemia: Therapeutic implications.

Fangli Chen, Xue Wu, Cristina Niculite

|Apr 21, 2020
A multi-institutional comparison of mitoxantrone, etoposide, and cytarabine vs high-dose cytarabine and mitoxantrone therapy for patients with relapsed or refractory acute myeloid leukemia.

Sonia Christian, Saad Arain, Pritesh Patel

|Jan 13, 2018
The rocky road to personalized medicine in acute myeloid leukaemia.

Bryan Brinda, Irum Khan, Brian Parkin

Pageof 1

Frequent Collaborators

2 joint publications

Xue Wu

1 joint publications

Pritesh Patel

1 joint publications

Gregory S Calip

1 joint publications

Karen Sweiss